Tag: Gain Therapeutics

Gain Therapeutics ($GANX) Shares Drop 6.4% Regular Trading Amid New Stock Offering

Gain Therapeutics (NASDAQ: GANX) shares are down 6.47% in day trading, currently priced at $1.59, following a previous close of $1.70. During Wednesday’s regular...

Gain Therapeutics, Inc. ($GANX) Moves Forward with Public Offering of 4.5 Million Shares

Gain Therapeutics, Inc. (GANX) announced the pricing of an underwritten public offering of 4,501,640 shares of its common stock. The public offering price for...